Intraoperative examination of sentinel lymph nodes by ultrarapid immunohistochemistry in breast cancer

Japanese Journal of Clinical Oncology

Volumn 36, Issue 8, 2006, Pages 489-493

  Choi, Young Jin ^a   Yun, Hae Ran ^a   Yoo, Ki Eun ^a   Kim, Jung Han ^a   Nam, Seok Jin ^a   Choi, Yoon La ^a   Ko, Young Hyeh ^a   Kim, Byung Tae ^a   Yang, Jung Hyun ^a  

^a Sungkyunkwan University School of Medicine   (South Korea)

Author keywords

Breast cancer; Micrometastasis; Sentinel lymph node; Ultrarapid immunohistochemistry (IHC)

Indexed keywords

CYTOKERATIN; EOSIN; HEMATOXYLIN;

ADULT; AGED; ARTICLE; AXILLARY LYMPH NODE; BREAST CANCER; CONTROLLED STUDY; DIAGNOSTIC ACCURACY; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; INTRAOPERATIVE PERIOD; LYMPH NODE DISSECTION; LYMPH NODE METASTASIS; MAJOR CLINICAL STUDY; MASTECTOMY; MICROMETASTASIS; RELIABILITY; SENSITIVITY AND SPECIFICITY; SENTINEL LYMPH NODE BIOPSY; TUMOR CELL;

ADULT; AGED; AXILLA; BREAST NEOPLASMS; FEMALE; FROZEN SECTIONS; HUMANS; IMMUNOHISTOCHEMISTRY; INTRAOPERATIVE CARE; KERATINS; LYMPH NODE EXCISION; LYMPH NODES; LYMPHATIC METASTASIS; MASTECTOMY; MIDDLE AGED; NEOPLASM STAGING; SENSITIVITY AND SPECIFICITY; SENTINEL LYMPH NODE BIOPSY;

EID: 33750104794     PISSN: 03682811     EISSN: 14653621     Source Type: Journal    
DOI: 10.1093/jjco/hyl045     Document Type: Article

References (22)

1. Carter CL, Allen C, Henson DE. Relation of tumor size, lymph node status, and survival in 24,740 breast cancer cases. Cancer 1989;63:181-7.
2. Fisher ER, Sass R, Fisher B. Pathologic findings from the National Surgical Adjuvant Project for Breast Cancers (protocol no. 4). X. Discriminants for tenth year treatment failure. Cancer 1984;53:712-23.
3. Recht A, Pierce SM, Abner A, Vicini F, Osteen RT, Love SM, et al. Regional nodal failure after conservative surgery and radiotherapy for early-stage breast carcinoma. J. Clin Oncol 1991;9:988-96.
4. Cady B, Stone MD, Schuler JG, Thakur R, Wanner MA, Lavin PT, The new era in breast cancer. Invasion, size, and nodal involvement dramatically decreasing as a result of mammographic screening. Arch Surg 1996;131:301-8.
5. Reed W, Bohler PJ, Sandstad B, Nesland JM. Occult metastases in axillary lymph nodes as a predictor of survival in node-negative breast carcinoma with long-term follow-up. Breast J 2004;10:174-80.
6. Hainsworth PJ, Tjandra JJ, Stillwell RG, Machet D, Henderson MA, Rennie GC, et al. Detection and significance of occult metastases in node-negative breast cancer. Br J Surg 1993;80:459-63.
7. Noguchi M. Therapeutic relevance of breast cancer micrometastases in sentinel lymph nodes. Br J Surg 2002;89:1505-15.
8. Moll R, Franke WW, Schiller DL, Geiger B, Krepler R. The catalog of human cytokeratins: Patterns of expression in normal epithelia, tumors and cultured cells. Cell 1982;31:11-24.
9. Lee IK, Jeong J, Chang HS, Park BW, Jung WH, Hong SW, et al. Intraoperative examination of sentinel lymph nodes using rapid cytokeratin immunohistochemical staining in breast cancer patients. J Korean Breast Cancer Soc 2004;7:154-60.
10. Cabanas RM. An approach for the treatment of penile carcinoma. Cancer 1977;39:456-66.
11. Morton DL, Wen DR, Wong JH, Economou IS, Cagle LA, Storm FK, et al. Technical details of intraoperative lymphatic mapping for early stage melanoma. Arch Surg 1992;127:392-9.
12. Giuliano AE, Kirgan DM, Guenther JM, Morton DL. Lymphatic mapping and sentinel lymphadenectomy for breast cancer. Ann Surg 1994;220:391-401.
13. Veronesi U, Paganelli G, Viale G, Galimberti V, Luini A, Zurrida S, et al. Sentinel lymph node biopsy and axillary dissection in breast cancer: results in a large series. J Natl Cancer Inst 1999;91:368-73.
14. Veronesi U, Paganelli G, Galimberti V, Viale G, Zurrida S, Bedoni M, et al. Sentinel-node biopsy to avoid axillary dissection in breast cancer with clinically negative lymph-nodes. Lancet 1997;349:1864-7.
15. Turner RR, Ollila DW, Krasne DL, Giuliano AE. Histopathologic validation of the sentinel lymph node hypothesis for breast carcinoma. Ann Surg 1997;226:271-8.
16. Pendas S, Dauway E, Cox CE, Giuliano R, Ku NN, Schreiber RH, et al. Sentinel node biopsy and cytokeratin staining for the accurate staging of 478 breast cancer patients. Am Surg 1999;65:500-6.
17. Nahrig JM, Richter T, Kuhn W, Avril N, Flatau B, Kowolik J, et al. Intraoperative examination of sentinel lymph nodes by ultrarapid immunohistochemistry. Breast J 2003;9:277-81.
18. Viale G, Bosari S, Mazszarol G, Galimberti V, Luini A, Veronesi P, et al. Intraoperative examination of axillary sentinel lymph nodes in breast carcinoma patients. Cancer 1999;85:2433-8.
19. Huvos AG, Hutter RV, Berg JW. Significance of axillary macrometastases and micrometastases in mammary cancer. Ann Surg 1971;173:44-6.
20. Dowlatshahi K, Fan M, Snider HC, Habib FA. Lymph node micrometastases from breast carcinoma: Reviewing the dilemma. Cancer 1997;80:1188-97.
21. Rosen PP, Saigo PE, Braun DW, Weathers E, Kinne DW. Prognosis in stage II (T1N1MO) breast cancer. Ann Surg 1981;194:576-84.
22. Viale G, Maiorano E, Pruneri G, Mastropasqua MG, Valentini S, Galimberti V, et al. Predicting the risk for additional axillary metastases in patients with breast carcinoma and positive sentinel lymph node biopsy. Ann Surg 2005;241:319-25.